Polyplastics announces commercial availability of DURACON POM PM Series for medical industry
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
This product will be manufactured at Lupin's Pithampur facility in India
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Subscribe To Our Newsletter & Stay Updated